Overview of Therapeutic Inertia in Diabetes: Prevalence, Causes, and Consequences.
Diabetes Spectr
; 33(1): 8-15, 2020 Feb.
Article
em En
| MEDLINE
| ID: mdl-32116448
ABSTRACT
Many people with diabetes do not achieve individualized treatment targets. Therapeutic inertia, the underuse of effective therapies in preventing serious clinical end points, is a frequent, important contributor to this failure. Clinicians, patients, health systems, payors, and producers of medications, devices, and other products for those with diabetes all play a role in the development of therapeutic inertia and can all help to reduce it.
Texto completo:
1
Base de dados:
MEDLINE
Tipo de estudo:
Etiology_studies
/
Prevalence_studies
/
Risk_factors_studies
Idioma:
En
Revista:
Diabetes Spectr
Ano de publicação:
2020
Tipo de documento:
Article
País de afiliação:
Laos